Pharma

Tackling AMR and medicine shortages in the EU

How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.

CBD Novel Foods in the UK

Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.

Benchmarking Regulatory systems governing veterinary medicines

Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.

Pharmaceuticals: Falsified medicines

Dr Ash Ramzan, Founder and Principal Consultant, Woodley BioReg Limited, turns the spotlight on falsified medicines in this pharmaceuticals focus.

Why are illegal pharma markets still prevalent today?

Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.

Cannabidiol, skin homeostasis and acne

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.

The UK’s legalisation of medicinal cannabis

David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.

COVID-19 and drugs in the European neighbourhood partnership countries

The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.

Medical cannabis in the UK and the industry’s future

Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.

Drug prices in the U.S. are 2.56 times higher

Prescription drug prices in the United States are 2.56 times higher than in other countries, according to a new RAND Corporation report.

Antibiotics provide no benefit to COVID-19 patients

The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.

Ivermectin effective in reducing mild COVID-19

A new study has found that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19.

EU finalises talks with Valneva to secure a new vaccine

Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.

Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine

Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.

Functionality of Hemp Proteins and their Peptides

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.

CBD oil and cancer: What the research shows

CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.

Can we live without pharmacology?

Aida Batista, Vice President of the European Association of Hospital Pharmacists (EAHP), explores if we can live without pharmacology, including comment on the use of opioid and sedative drugs.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders